IRIS
Merli, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.566
NA - Nord America 1.055
SA - Sud America 611
EU - Europa 188
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.508
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 968
SG - Singapore 621
BR - Brasile 465
CN - Cina 291
HK - Hong Kong 213
VN - Vietnam 104
IT - Italia 86
IN - India 72
AR - Argentina 60
BD - Bangladesh 52
MX - Messico 47
ID - Indonesia 28
IQ - Iraq 23
TR - Turchia 23
VE - Venezuela 21
MY - Malesia 20
PK - Pakistan 20
SA - Arabia Saudita 19
UZ - Uzbekistan 19
CO - Colombia 18
MA - Marocco 18
ZA - Sudafrica 18
EC - Ecuador 17
PH - Filippine 14
FR - Francia 13
GB - Regno Unito 13
CA - Canada 11
PY - Paraguay 11
DE - Germania 10
TN - Tunisia 10
NL - Olanda 9
RU - Federazione Russa 9
UA - Ucraina 9
EG - Egitto 8
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
KE - Kenya 6
PE - Perù 6
NP - Nepal 5
AZ - Azerbaigian 4
BB - Barbados 4
HN - Honduras 4
JM - Giamaica 4
LY - Libia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
ES - Italia 3
IE - Irlanda 3
JO - Giordania 3
LC - Santa Lucia 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
SE - Svezia 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
BO - Bolivia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
FI - Finlandia 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
MG - Madagascar 2
MU - Mauritius 2
NO - Norvegia 2
PA - Panama 2
PL - Polonia 2
AL - Albania 1
BE - Belgio 1
BG - Bulgaria 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
IR - Iran 1
IS - Islanda 1
JP - Giappone 1
KH - Cambogia 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
Totale 3.497
Salva come PNG Salva come JPEG
Città #
San Jose 678
Singapore 316
Hong Kong 207
Beijing 152
Ashburn 138
Ho Chi Minh City 47
Rome 39
São Paulo 33
Mexico City 31
Hanoi 24
Rio de Janeiro 19
Tashkent 17
Belo Horizonte 13
Brasília 13
Dhaka 13
Kuala Lumpur 10
Medellín 10
Santa Clara 10
Baghdad 9
Council Bluffs 9
Casablanca 8
Curitiba 8
Istanbul 7
Jeddah 7
Asunción 6
Buenos Aires 6
Lahore 6
Milan 6
Salvador 6
Xi'an 6
Biên Hòa 5
Cairo 5
Caracas 5
Faisalabad 5
Guayaquil 5
Johannesburg 5
Juiz de Fora 5
Manaus 5
Nairobi 5
New York 5
Pelotas 5
Porto Alegre 5
Quito 5
Rabat 5
Shanghai 5
Ahmedabad 4
Belém 4
Bengaluru 4
Bridgetown 4
Campinas 4
Dammam 4
Delhi 4
Dubai 4
Joinville 4
Kathmandu 4
Medina 4
Ribeirão Preto 4
Valencia 4
Belgrade 3
Betim 3
Cape Town 3
Carapicuíba 3
Castries 3
Caxias do Sul 3
Ciudad del Este 3
Contagem 3
Doha 3
Durban 3
Fortaleza 3
Guangzhou 3
Hortolândia 3
Hyderabad 3
Jakarta 3
Karbala 3
Lima 3
Montevideo 3
Morlaàs 3
New Delhi 3
Petrolina 3
Phủ Lý 3
Praia Grande 3
Ribeirão das Neves 3
Riyadh 3
San Juan 3
Sorocaba 3
São Gonçalo 3
São José dos Campos 3
The Bronx 3
The Dalles 3
Thái Bình 3
Tripoli 3
Turin 3
Ambato 2
Amman 2
Ankara 2
Antananarivo 2
Aracaju 2
Araras 2
Araucária 2
Baku 2
Totale 2.099
Salva come PNG Salva come JPEG
Nome #
Oral manifestations and complications in childhood acute myeloid leukemia 49
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 43
CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia 41
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD 40
TCR alpha beta/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders 39
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis 39
A Day 14 Endpoint for Acute GVHD Clinical Trials 37
Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes 37
Hematopoietic stem cell transplantation in neuromyelitis optica-spectrum disorders (NMO-SD): State-of-the-art and future perspectives 36
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 36
Outcome of children with acute leukemia given HLA-haploidentical HSCT after alpha beta T-cell and B-cell depletion 36
Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience 35
Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation 35
At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies 35
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies 35
Natural killer cells in the treatment of high-risk acute leukaemia 35
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation 35
Expansion of CD4(dim)CD(8+) T cells characterizes macrophage activation syndrome and other secondary HLH 34
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform 34
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 34
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 34
Fecal microbiota transplantation for decolonization from multidrug-resistant bacteria in pediatric allogeneic hematopoietic stem cell transplantation recipients: a retrospective real-word data study 33
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group 33
Use of ruxolitinib to control graft-versus-host-like disease in Omenn syndrome and successfully bridging to HSCT 33
Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia 33
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 33
Allogeneic, donor-derived, second-generation, CD19-CAR-T cell for the treatment of pediatric relapsed/refractory BCP-ALL 32
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome 31
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells 31
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease 31
Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy 31
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 31
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 31
Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation 31
Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT 31
B-cell depleting immunotherapies: therapeutic opportunities and toxicities 31
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management 31
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 31
Preservation of antigen-specific Functions of alpha beta T cells and B cells removed from hematopoietic stem cell Transplants suggests Their Use as an alternative cell source for advanced Manipulation and adoptiveimmunotherapy Immunotheraphy 31
Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL) 31
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with alpha-1-antitrypsin 31
Agenesis of Internal Carotid Artery and Hypopituitarism: Case Report and Review of Literature 31
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification 30
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 30
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children 30
Zoledronic acid boosts gamma delta T-cell activity in children receiving alpha beta(+) T and CD19(+) cell-depleted grafts from an HLA-haplo-identical donor 30
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III 30
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol 30
Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications 29
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial 29
QuantiFERON-TB Gold can help clinicians in the diagnosis of haemophagocytic lymphohistiocytosis 29
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group 29
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease 29
TCR alpha beta/CD19 depleted hematopoietic stem cell transplantation from haploidentical donors: dissecting the GvL/GvHD conundrum 29
Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis 29
alpha beta T- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes 29
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation 28
The utility of biomarkers in acute GVHD prognostication 28
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD 28
Novel Compound Heterozygous Mutations in IL-7 Receptor alpha Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment 28
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia 28
Effectiveness of emicizumab in preventing life-threatening bleeding complications in type 3 von Willebrand disease with inhibitors: A paediatric report 28
Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant 28
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy 28
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 28
T cell therapy for nasopharyngeal carcinoma 28
Phenotypic and functional characterization of nk cells in αβt-cell and b-cell depleted haplo-hsct to cure pediatric patients with acute leukemia 27
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis 27
Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors 27
Role of interferon-gamma in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation 27
Strategies To Increase CAR T-Cell Safety and to Prevent Epitope Masking In CAR plus B-Cell Leukemia Blasts 27
Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia 27
Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection 26
The changing role of stem cell transplantation in childhood 26
Fecal microbiota transplant in two ulcerative colitis pediatric cases: Gut microbiota and clinical course correlations 26
GATA2 and marrow failure 26
Nasal Disease and Asthma 26
NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation 26
Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia 26
Case Report: Massive Intestinal Pneumatosis and Pneumoretroperitoneum Following Hematopoietic Stem Cell Transplantation in a 2-Year-Old Child 25
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease 25
Progressive increase in D-dimer levels during extracorporeal membrane oxygenation can predict membrane oxygenator failure in children given hematopoietic stem cell transplantation? 25
NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart 25
Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: gut microbiota profiling, infectious and clinical outcomes 25
Non-response to vaccines: still an enigma? B-cell transcription factor POU2F2/OCT2 is a potential candidate 25
Treating second-relapsed/refractory first-relapsed childhood acute myeloid leukaemia: Successful salvage rather than palliation? 25
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients 25
Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia 25
TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis 25
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation 25
Eltrombopag for treatment of thrombocytopenia-associated disorders 25
Reconstitution of multifunctional CD56(low)CD16(low) natural killer cell subset in children with acute leukemia given / T cell-depleted HLA-haploidentical haematopoietic stem cell transplantation 24
Immunoselection techniques in hematopoietic stem cell transplantation 24
Current state of musculoskeletal ultrasound in paediatric rheumatology: results of an international survey 24
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers 24
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 24
Truncated form of human CD19 antigen as a suicide gene to control T-cell alloreactivity: ΔCD19 24
Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients 24
Immune Modulation Properties of Zoledronic Acid on TcR gamma delta T-Lymphocytes After TcR alpha beta/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia 24
Rabbit anti-human T-lymphocyte globulin and hematopoietic transplantation 23
Totale 2.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025905 0 0 0 122 21 6 67 123 35 25 218 288
2025/20262.735 165 17 235 203 340 164 297 159 740 415 0 0
Totale 3.640